Praxis Precision Medicines, Inc. (PRAX)
308.99
-3.91
(-1.25%)
USD |
NASDAQ |
Sep 16, 16:00
311.20
+2.21
(+0.72%)
Pre-Market: 08:13
Praxis Precision Medicines Shareholders Equity (Quarterly) : 1.341B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.341B |
| March 31, 2026 | 1.410B |
| December 31, 2025 | 878.14M |
| September 30, 2025 | 343.50M |
| June 30, 2025 | 404.22M |
| March 31, 2025 | 439.21M |
| December 31, 2024 | 445.45M |
| September 30, 2024 | 382.67M |
| June 30, 2024 | 419.10M |
| March 31, 2024 | 229.68M |
| December 31, 2023 | 69.67M |
| September 30, 2023 | 86.76M |
| June 30, 2023 | 105.62M |
| March 31, 2023 | 64.47M |
| Date | Value |
|---|---|
| December 31, 2022 | 76.11M |
| September 30, 2022 | 105.16M |
| June 30, 2022 | 138.87M |
| March 31, 2022 | 191.02M |
| December 31, 2021 | 250.81M |
| September 30, 2021 | 295.92M |
| June 30, 2021 | 333.77M |
| March 31, 2021 | 265.52M |
| December 31, 2020 | 287.46M |
| September 30, 2020 | 108.97M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 40.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 757.49M |
| Perspective Therapeutics, Inc. | 323.86M |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| AbbVie, Inc. | -5.935B |
| TG Therapeutics, Inc. | 604.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.390B |
| Total Liabilities (Quarterly) | 49.06M |
| Debt to Equity Ratio | 0.0008 |
| Current Ratio | 15.73 |